RayzeBio: Audience

RayzeBio is a vertically integrated radiopharmaceutical therapeutics company dedicated to improving cancer patient survival through the development of targeted innovative drugs that utilize radioisotopes. The company focuses on creating a diverse portfolio of radiopharmaceutical drug candidates, advancing them from discovery to late-stage clinical programs.